Species-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPARalpha.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Toxicological Sciences

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/toxsci/kfn062PMID 18375545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.

  2007cited by this paper
• Peroxisome Proliferator-Activated Receptor α Regulates a MicroRNA-Mediated Signaling Cascade Responsible for Hepatocellular Proliferation

  2007cited by this paper
• Critical Role for Transcription Coactivator Peroxisome Proliferator-activated Receptor (PPAR)-binding Protein/TRAP220 in Liver Regeneration and PPARα Ligand-induced Liver Tumor Development*

  2007cited by this paper
• Apc tumor suppressor gene is the "zonation-keeper" of mouse liver.

  2006cited by this paper
• Conditional deletion of beta-catenin reveals its role in liver growth and regeneration.

  2006cited by this paper
• The origins and uses of mouse outbred stocks

  2005cited by this paper
• Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand?

  2005cited by this paper
• Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

  2005cited by this paper
• Molecular analysis of peroxisome proliferation in the hamster.

  2004cited by this paper
• Peroxisome proliferator-activated receptor α target genes

  2004cited by this paper
• Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.

  2003cited by this paper
• Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP.

  2003cited by this paper
• PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

  2003cited by this paper
• The molecular physiology of liver regeneration following partial hepatectomy

  2003cited by this paper
• PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance

  2003cited by this paper
• Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor alpha.

  2002cited by this paper
• Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor α

  2002influential reference
• Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli

  2002cited by this paper
• Peroxisome Proliferator-activated Receptor-α Regulates Lipid Homeostasis, but Is Not Associated with Obesity

  2001cited by this paper
• Timing of hepatocyte entry into DNA synthesis after partial hepatectomy is cell autonomous.

  2000cited by this paper
• The Effects of Prolonged Administration of 5-Bromodeoxyuridine on Cells of the Immune System1

  2000cited by this paper
• Genealogies of mouse inbred strains

  2000cited by this paper
• Species differences in peroxisome proliferation; mechanisms and relevance.

  2000cited by this paper
• Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.

  1998cited by this paper
• The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate.

  1998cited by this paper
• The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis.

  1998cited by this paper
• Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

  1997influential reference
• Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF‐κB and AP‐1 or with expression of tumor necrosis factor α

  1997cited by this paper
• Long-term Oral Application of 5-Bromo-2-Deoxyuridine Does Not Reliably Label Proliferating Immune Cells in the LEW Rat

  1997cited by this paper
• Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha.

  1997cited by this paper
• The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats.

  1996cited by this paper
• Comparative Toxicology of Hypolipidaemic Fibrates

  1996cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper
• Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes.

  1995cited by this paper
• Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice.

  1994cited by this paper
• Pretranslational induction of cytochrome P4501A enzymes by beta-naphthoflavone and 3-methylcholanthrene occurs in different liver zones.

  1994cited by this paper
• Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis

  1994cited by this paper
• Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver.

  1993influential reference
• Induction of cytochrome P450 and peroxisomal enzymes by clofibric acid in vivo and in vitro.

  1993cited by this paper
• Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and livermitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL6N and BALBc mice

  1992cited by this paper
• Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL/6N and BALB/c mice.

  1992cited by this paper
• Zone-specific inducibility of cytochrome P450 2B1/2 is retained in isolated perivenous hepatocytes.

  1992cited by this paper
• Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver.

  1991cited by this paper
• Localization and differential induction of cytochrome P450IVA and acyl-CoA oxidase in rat liver.

  1991cited by this paper
• Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators.

  1991cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump.

  1990cited by this paper
• Effects produced by the non-genotoxic hepatocarcinogen methylclofenapate in dwarf mice: peroxisome induction uncoupled from DNA synthesis and nuclearity changes.

  1990influential reference
• Comparison of the Peroxisome Proliferator-Induced Pleiotropic Response in the Liver of Nine Strains of Mice

  1989cited by this paper
• Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.

  1988cited by this paper
• A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyte.

  1988influential reference
• A cytological comparison between regeneration, hyperplasia and early neoplasia in the rat liver.

  1987cited by this paper
• Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

  1980cited by this paper

• Ameliorating Effect of Green Tea Aqueous Extract against Histo pathophysiological Changes Induced by Ciprofibrate in the liver of Male Albino Rats

  2020cites this paper
• Treatment with DHA Improves Epidermal Eeratinocyte Differentiation and Ameliorates Inflammation in Human Keratinocytes and Reconstructed Human Epidermis Models

  2019cites this paper
• Treatment with Docosahexaenoic Acid Improves Epidermal Keratinocyte Differentiation and Ameliorates Inflammation in Human Keratinocytes and Reconstructed Human Epidermis Models

  2019cites this paper
• Chemicals with Carcinogenic Activity Primarily in Rodent Liver

  2018cites this paper
• Towards a better understanding of early drug-induced regulatory mechanisms of liver tumorigenesis

  2014cites this paper
• Genes involved in the induction of liver growth by peroxisome proliferators

  2014cites this paper
• Expression et fonction de l’adiponutrine/PNPLA3 dans le foie : Relation entre la voie Wnt/β-caténine, la sensibilité à l’insuline et la stéatose hépatique

  2012cites this paper
• Organotypic Modeling of Human Keratinocyte Response to Peroxisome Proliferators

  2012cites this paper
• Hepatocyte Growth, Proliferation and Experimental Carcinogenesis

  2011cites this paper
• Chemicals with Carcinogenic Activity in Rodent Liver

  2010cites this paper
• Mechanism of action of liver growth induced by peroxisome proliferators

  2010cites this paper
• TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells.

  2010cites this paper
• Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation

  2009cites this paper